Patents by Inventor Rosel KRETSCHMER-KAZEMI FAR

Rosel KRETSCHMER-KAZEMI FAR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antisense drugs against canine ICAM-1 for use in the treatment of inflammation of the buccal cavity
    Patent number: 11773394
    Abstract: The present invention relates to an isolated antisense oligonucleotide for use in a method of preventing or treating an inflammatory disease or condition of the buccal cavity in a canine subject, wherein said antisense oligonucleotide is directed against canine ICAM-1. The present invention further relates to compositions or articles of manufacture comprising said antisense oligonucleotide.
    Type: Grant
    Filed: April 16, 2021
    Date of Patent: October 3, 2023
    Assignee: Universität zu Lübeck
    Inventors: Georg Sczakiel, Rosel Kretschmer-Kazemi Far, Franziska Preuss
  • Antisense Drug Against the Human Intercellular Adhesion Molecule 1 (ICAM-1)
    Publication number: 20220106601
    Abstract: The present invention relates to a specific antisense oligonucleotide which inhibits the expression of the adhesion molecule ICAM-1 in human cells. The present invention further relates to a vector containing said oligonucleotide and a host cell containing said vector or oligonucleotide and a pharmaceutical composition containing said oligonucleotide as well as uses thereof, in particular in the treatment of an inflammatory disease or condition in humans.
    Type: Application
    Filed: December 17, 2019
    Publication date: April 7, 2022
    Applicant: Universität Zu Lübeck
    Inventors: Georg Sczakiel, Rosel Kretschmer-Kazemi Far
  • ANTISENSE DRUGS AGAINST CANINE ICAM-1 FOR USE IN THE TREATMENT OF INFLAMMATION OF THE BUCCAL CAVITY
    Publication number: 20210310009
    Abstract: The present invention relates to an isolated antisense oligonucleotide for use in a method of preventing or treating an inflammatory disease or condition of the buccal cavity in a canine subject, wherein said antisense oligonucleotide is directed against canine ICAM-1. The present invention further relates to compositions or articles of manufacture comprising said antisense oligonucleotide.
    Type: Application
    Filed: April 16, 2021
    Publication date: October 7, 2021
    Applicant: UNIVERSITÄT ZU LÜBECK
    Inventors: Georg SCZAKIEL, Rosel KRETSCHMER-KAZEMI FAR, Franziska PREUSS
  • Antisense drugs against canine ICAM-1 for use in the treatment of inflammation of the buccal cavity
    Patent number: 11008574
    Abstract: The present invention relates to an isolated antisense oligonucleotide for use in a method of preventing or treating an inflammatory disease or condition of the buccal cavity in a canine subject, wherein said antisense oligonucleotide is directed against canine ICAM-1. The present invention further relates to compositions or articles of manufacture comprising said antisense oligonucleotide.
    Type: Grant
    Filed: July 11, 2018
    Date of Patent: May 18, 2021
    Assignee: Universität zu Lübeck
    Inventors: Georg Sczakiel, Rosel Kretschmer-Kazemi Far, Franziska Preuss
  • ANTISENSE DRUGS AGAINST CANINE ICAM-1 FOR USE IN THE TREATMENT OF INFLAMMATION OF THE BUCCAL CAVITY
    Publication number: 20200239894
    Abstract: The present invention relates to an isolated antisense oligonucleotide for use in a method of preventing or treating an inflammatory disease or condition of the buccal cavity in a canine subject, wherein said antisense oligonucleotide is directed against canine ICAM-1. The present invention further relates to compositions or articles of manufacture comprising said antisense oligonucleotide.
    Type: Application
    Filed: July 11, 2018
    Publication date: July 30, 2020
    Inventors: Georg SCZAKIEL, Rosel KRETSCHMER-KAZEMI FAR, Franziska PREUSS